医学
中医药
替代医学
传统医学
绝经后骨质疏松症
药方
随机对照试验
骨质疏松症
不利影响
家庭医学
梅德林
中成药
内科学
药理学
骨矿物
病理
政治学
法学
作者
J. Li,Shu‐fei Fu,Yifei Yang,R. An,Hongyan Liu,Haoping Mao
出处
期刊:Climacteric
[Informa]
日期:2022-08-02
卷期号:25 (6): 562-569
被引量:9
标识
DOI:10.1080/13697137.2022.2102894
摘要
Objective This study aimed to evaluate the effectiveness and safety of traditional Chinese medicine (TCM) for postmenopausal osteoporosis (PMOP).Methods We conducted a computer literature search in five databases and comprehensively extracted all kinds of information from each article. Traditional Chinese medicine inheritance support system (TCMISS) V2.5 was adopted to perform association analysis. The effectiveness, safety and methodological quality were analyzed using randomized controlled clinical trials (RCTs).Results A total of 2880 related articles were collected. Finally, 423 articles which included 312 RCTs were included for in-depth analysis. We collected 369 Chinese medicine prescriptions and found that the top three frequently used herbs in the treatment of PMOP were Epimedii Folium (Yinyanghuo), Rehmanniae Radix Praeparata (Shudihuang) and Angelicae Sinensis Radix (Danggui). The top Chinese patent medicine was Gushukang capsule. No serious adverse reaction (AR) had been reported in the Chinese medical treatment group.Conclusion The effectiveness of TCM in treating PMOP needs to be further explored, and the safety is good. Therefore, high-quality evidence is urgently needed to supplement.
科研通智能强力驱动
Strongly Powered by AbleSci AI